(Q86299876)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Filippo Ceccato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Carla Scaroni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

N Albiger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Zilio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A C Frigo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

L Denaro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

F Mantero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

109-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11102-013-0475-3

25 February 2020

exact match

0 references

cites work

Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.

1 reference

12 December 2020

The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery

1 reference

12 December 2020

Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor

1 reference

12 December 2020

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

1 reference

12 December 2020

Dopamine agonists and pituitary tumor shrinkage

1 reference

12 December 2020

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease

1 reference

12 December 2020

Cabergoline monotherapy in the long-term treatment of Cushing's disease

1 reference

12 December 2020

Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.

1 reference

12 December 2020

Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease

1 reference

12 December 2020

Ketoconazole treatment in Cushing's syndrome: experience in 34 patients

1 reference

12 December 2020

Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy.

1 reference

12 December 2020

Late recurrences of Cushing's disease after initial successful transsphenoidal surgery

1 reference

12 December 2020

Dopamine receptor expression and function in corticotroph pituitary tumors

1 reference

12 December 2020

Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.

1 reference

12 December 2020

Management of Cushing disease

1 reference

12 December 2020

The use of ketoconazole as an inhibitor of steroid production

1 reference

12 December 2020

Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years

1 reference

12 December 2020

Potential role for retinoic acid in patients with Cushing's disease

1 reference

12 December 2020

Retinoic acid prevents experimental Cushing syndrome

1 reference

12 December 2020

Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline

1 reference

12 December 2020

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

1 reference

12 December 2020

New medical approaches in pituitary adenomas

1 reference

12 December 2020

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease

1 reference

12 December 2020

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro

1 reference

12 December 2020

Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis

1 reference

12 December 2020

Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery.

1 reference

12 December 2020

Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance

1 reference

12 December 2020

The influence of ketoconazole on human adrenal steroidogenesis: incubation studies with tissue slices

1 reference

12 December 2020

Dopamine: a role in the pathogenesis and treatment of hypertension

1 reference

12 December 2020

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

1 reference

12 December 2020

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

1 reference

12 December 2020

Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group

1 reference

12 December 2020

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

1 reference

12 December 2020

Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.

1 reference

12 December 2020

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

1 reference

12 December 2020

Medical therapy for Cushing's disease

1 reference

12 December 2020

Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency

1 reference

12 December 2020

The Mechanism of the Suppressive Action of Bromocriptine on Adrenocorticotropin Secretion in Patients with Cushing′s Disease and Nelson′s Syndrome*

1 reference

12 December 2020

10.1007/S11102-013-0475-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23468128%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference